Overview Indian Pharmaceutical Market (IPM)Dec’2020
The year 2020 has actually been a challenging year for many sectors. However, the Indian Pharma sector has managed this challenging situation with a positive growth record.
The motivating trends in the last couple of months hint towards a near-normal revival for most companies.
The COVID situation has impacted the IPM, and the trend of growth in Nov '20 with 1.0% has enhanced to 8.5% in Dec'20. Some therapies continue the trend of revival on Dec 20.
Snap shot of Top 7 Therapies
- Cardiac registered a monthly growth of 14.9% compared to 8.7 % in Nov’20.
- Anti-Diabetic registered growth of 9.9% compared to 1.9% in Nov '20.
- Respiratory medicines growth slumps to -8.7% compared to -6.9 % in Nov ’20.
- Post Unlock down since June’20 the struggle for Anti-infectives 0.2% in Nov 20 continues 5.2% in Dec 20.
- Gastro exhibits growth of 16.2 % vs 3.1% in Nov’20.
- Vitamins have bounced back has growth of 14.0% in Dec Vs 6.6 % Nov 20 and
- Pain & Analgesics are at 6.0% in Dec’20 vs -5.2 % in Nov 20.
Note: -Rest of the therapies will be discussed later.
IPM (Indian Pharmaceutical Market)-Top 100 Companies-Dec'20
MAT-Moving Annual Total(Cumulative data for last one year)
MS-Market Share
MTH-Month, Dec'20
GR-Growth Rate
All data figure in crore
